Timothy F. Cloughesy

发表

NIMG-08. EVALUATING THE APPLICABILITY OF TUMOR PROBABILITY MAPS AS A RESOURCE FOR IMPROVED BRAIN TUMOR SEGMENTATION

Ricky K. Taira, Alex A. T. Bui, William Hsu, 2017 .

Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas

Robert J. Harris, Albert Lai, Whitney B. Pope, 2012, NeuroImage.

A Tool for Improving the Longitudinal Imaging Characterization for Neuro-Oncology Cases

Ricky K. Taira, Alex A. T. Bui, Hooshang Kangarloo, 2008, AMIA.

Content-based Image Retrieval of Glioblastoma Multiforme

Suzie El-Saden, Timothy F. Cloughesy, Shishir Dube, 2007 .

Hierarchical segmentation of malignant gliomas via integrated contextual filter response

Alan L. Yuille, Jason J. Corso, Suzie El-Saden, 2008, SPIE Medical Imaging.

Synthesizing MR Image Contrast Enhancement Using 3D High-resolution ConvNets pdf

Xinyu Jin, Corey W. Arnold, Benjamin M. Ellingson, 2021, ArXiv.

Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage

Ivan Babic, Albert Lai, Donatello Telesca, 2013, Journal of Neuro-Oncology.

Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas

Robert J. Harris, Albert Lai, William H. Yong, 2015, Molecular Imaging and Biology.

Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab

Albert Lai, Whitney B. Pope, Benjamin M. Ellingson, 2011, Journal of Neuro-Oncology.

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Howard A. Fine, Susan Chang, Frank Lieberman, 2006, Clinical Cancer Research.

High order diffusion tensor imaging in human glioblastoma.

Albert Lai, Whitney B. Pope, Timothy F. Cloughesy, 2011, Academic radiology.

Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab

Albert Lai, Whitney B. Pope, Benjamin M. Ellingson, 2011, Journal of Neuro-Oncology.

Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI

Susan Y. Bookheimer, Robert J. Harris, Albert Lai, 2013, Journal of Neuro-Oncology.

Automated MR image processing and analysis of malignant brain tumors: enabling technology for data mining

Alan L. Yuille, Usha Sinha, Jason J. Corso, 2007 .

16 – Structural and Functional Imaging of Cerebral Neoplasia

Timothy F. Cloughesy, Jeffry R. Alger, T. Cloughesy, 2000 .

Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric

Kristin R. Swanson, Maxwell Lewis Neal, Russell C. Rockne, 2013, PloS one.

Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone

Stanley F. Nelson, Albert Lai, Whitney B. Pope, 2009, Journal of Neuro-Oncology.

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials

Benjamin M. Ellingson, Timothy F. Cloughesy, Patrick Y. Wen, 2017, Neurotherapeutics.

A modeling-based factor extraction method for determining spatial heterogeneity of Ga-68 EDTA kinetics in brain tumors

Keith L. Black, Yun Zhou, Carl K. Hoh, 1996 .

Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance

Webster K. Cavenee, William H. Yong, Kenta Masui, 2015, Proceedings of the National Academy of Sciences.

Relationships Between Choline Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficient and Quantitative Histopathology in Human Glioma

Usha Sinha, Jorge Lazareff, Timothy F. Cloughesy, 2000, Journal of Neuro-Oncology.

Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression.

Kristin R. Swanson, Maxwell Lewis Neal, Russell C. Rockne, 2013, Cancer research.

EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling.

Webster K. Cavenee, Bing Ren, Gary C. Hon, 2015, Molecular cell.

Adaptive platform trials: definition, design, conduct and reporting considerations

Herman Goossens, Donald A. Berry, Lorenzo Trippa, 2019, Nature Reviews Drug Discovery.

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

Hong Wu, Albert Lai, William H. Yong, 2012, Journal of Neuro-Oncology.

Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

Timothy F. Cloughesy, Robert M. Prins, M. Roth, 2005, Clinical Cancer Research.

Brain Tumor Immunotherapy

Darell D. Bigner, Timothy F. Cloughesy, Donald P. Becker, 2000, Humana Press.

Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide

Stanley F. Nelson, Albert Lai, William H. Yong, 2015, Molecular Cancer.

Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas

Albert Lai, Whitney B. Pope, Benjamin M. Ellingson, 2020, Journal of Neuro-Oncology.

18F-FLT and 18F-FDOPA PET kinetics in recurrent brain tumors

Michael E. Phelps, Sung-Cheng Huang, Mirwais Wardak, 2014, European Journal of Nuclear Medicine and Molecular Imaging.